Blue Jet Healthcare Limited Fundamental Analysis
Blue Jet Healthcare Limited (BLUEJET.NS) shows moderate financial fundamentals with a PE ratio of 36.71, profit margin of 26.16%, and ROE of 20.31%. The company generates $9.5B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 89.7/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze BLUEJET.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBLUEJET.NS demonstrates superior asset utilization.
Valuation Score
ModerateBLUEJET.NS shows balanced valuation metrics.
Growth Score
ModerateBLUEJET.NS shows steady but slowing expansion.
Financial Health Score
ExcellentBLUEJET.NS maintains a strong and stable balance sheet.
Profitability Score
ExcellentBLUEJET.NS achieves industry-leading margins.
Key Financial Metrics
Is BLUEJET.NS Expensive or Cheap?
P/E Ratio
BLUEJET.NS trades at 36.71 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, BLUEJET.NS's PEG of -1.96 indicates potential undervaluation.
Price to Book
The market values Blue Jet Healthcare Limited at 6.70 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 28.21 times EBITDA. This signals the market has high growth expectations.
How Well Does BLUEJET.NS Make Money?
Net Profit Margin
For every $100 in sales, Blue Jet Healthcare Limited keeps $26.16 as profit after all expenses.
Operating Margin
Core operations generate 28.51 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $20.31 in profit for every $100 of shareholder equity.
ROA
Blue Jet Healthcare Limited generates $15.10 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Blue Jet Healthcare Limited produces operating cash flow of $2.07B, showing steady but balanced cash generation.
Free Cash Flow
Blue Jet Healthcare Limited produces free cash flow of $817.37M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $4.71 in free cash annually.
FCF Yield
BLUEJET.NS converts 0.90% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
36.71
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-1.96
vs 25 benchmark
P/B Ratio
Price to book value ratio
6.70
vs 25 benchmark
P/S Ratio
Price to sales ratio
9.61
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.03
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.21
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.20
vs 25 benchmark
ROA
Return on assets percentage
0.15
vs 25 benchmark
ROCE
Return on capital employed
0.19
vs 25 benchmark
How BLUEJET.NS Stacks Against Its Sector Peers
| Metric | BLUEJET.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 36.71 | 29.63 | Worse (Expensive) |
| ROE | 20.31% | 223.00% | Weak |
| Net Margin | 26.16% | -38669.00% (disorted) | Strong |
| Debt/Equity | 0.03 | 0.82 | Strong (Low Leverage) |
| Current Ratio | 4.21 | 4.30 | Strong Liquidity |
| ROA | 15.10% | -379.00% (disorted) | Strong |
BLUEJET.NS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Blue Jet Healthcare Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation